4.8 Article

hCAF1/CNOT7 regulates interferon signalling by targeting STAT1

期刊

EMBO JOURNAL
卷 32, 期 5, 页码 688-700

出版社

WILEY
DOI: 10.1038/emboj.2013.11

关键词

CCR4-NOT; deadenylation; hCAF1/CNOT7; interferon signalling; STAT1

资金

  1. Ligue Nationale Contre le Cancer (Equipe labellisee)
  2. 'Association pour la Recherche sur le Cancer' (ARC)
  3. Region Rhone-Alpes ARC1-Sante
  4. French Ministry of Research
  5. ARC
  6. Ligue Nationale Contre le Cancer
  7. Comite de la Loire

向作者/读者索取更多资源

Stringent regulation of the interferon (IFN) signalling pathway is essential for maintaining the immune response to pathogens and tumours. The transcription factor STAT1 is a crucial mediator of this response. Here, we show that hCAF1/CNOT7 regulates class I and II IFN pathways at different crucial steps. In resting cells, hCAF1 can control STAT1 trafficking by interacting with the latent form of STAT1 in the cytoplasm. IFN treatment induces STAT1 release, suggesting that hCAF1 may shield cytoplasmic STAT1 from undesirable stimulation. Consistently, hCAF1 silencing enhances STAT1 basal promoter occupancy associated with increased expression of a subset of STAT1-regulated genes. Consequently, hCAF1 knockdown cells exhibit an increased protection against viral infection and reduced viral replication. Furthermore, hCAF1 participates in the extinction of the IFN signal, through its deadenylase activity, by speeding up the degradation of some STAT1-regulated mRNAs. Since abnormal and unbalanced JAK/STAT activation is associated with immune disorders and cancer, hCAF1 could play a major role in innate immunity and oncogenesis, contributing to tumour escape. The EMBO Journal (2013) 32, 688-700. doi:10.1038/emboj.2013.11; Published online 5 February 2013

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据